| Literature DB >> 35693872 |
Xinlong Wan1,2, Xuan Shi3, Mengke Li1,2, Qing Chen1,2, Chang Xue1,2, Guanghui Li1,2, Yeke Huang4, Jingwen Yang3, Chan Chen3, Zhiyi Wang5, Shumei Ma1,2, Xiaodong Liu1,2.
Abstract
Radiation-induced lung injuries (RILI) is one of the serious complications of radiotherapy posed by the damage of alveolar cells and inflammation over-reaction. We aimed to investigate the potential protective effects of doxepin on RILI (20 Gy total dose at 3 Gy/min of X-ray irradiation), as well as its underlying mechanism. For animal experiments, such parameters as Immunohistochemistry and hematoxylin and eosin (H&E) staining, WBC (white blood cell), CRP (C-reactive protein), Western blot, and q-PCR were detected. The results indicated that both survival status and weight increase of irradiated rats treated by doxepin (3 mg/kg/day, rat) were higher than those of treated with irradiation alone (Dosing started the day before irradiation). Further, histological examinations showed doxepin could tenuate the radiation injury, as indicated as alveolar inflammatory exudation and there was only mild interstitial inflammation infiltration. Western blotting and q-PCR showed that expression of NF-κβ in X group were higher than that in XMD group. For the first time, we reported doxepin functioned as a radioprotectant candidate, which provide a promising application of doxepin for protecting radiotherapy injuries.Entities:
Keywords: JNK; NF-κβ; doxepin; radiation-induced lung injuries
Year: 2022 PMID: 35693872 PMCID: PMC9178985 DOI: 10.1177/15593258221107193
Source DB: PubMed Journal: Dose Response ISSN: 1559-3258 Impact factor: 2.623
Primer sequences for Quantitative Real-Time -PCR.
| Gene | Forward prime (5ʹ-3ʹ) | Reverse prime (5ʹ-3ʹ) | Reference |
|---|---|---|---|
| NF-κβ | ACCTGAGTCTTCTGGACCGCTG | CCAGCCTTCTCCCAAGAGTCGT | [19] |
| JNK | TGTGTGGAATCAAGCACCTTC | AGGCGTCATCATAAAACTCGTTC | [20] |
| β-actin | CGTGGACATCCGCAAAGACCTG | TGGGAGCCAGAGCAGTGATCTC | None |
Figure 1.Experiment flow chart, survival and weight change chart of each group. (A) Experiment flow chart, grouping situation and experiments done in this paper (B)Timeline of irradiation administration in animal experiments. (C) Survival status of each group. (D) weight changes of each group.
Summary and comparison of clinical symptoms of rats in each group (n = 8).
| C group | D group | X group | XLD group | XMD group | XHD group | |
|---|---|---|---|---|---|---|
| Attention | N | N | ↓↓↓ | ↓↓ | ↓ | ↓ |
| Agility | N | N | ↓↓ | ↓ | ↓ | ↓ |
| Appetite | N | N | ↓↓↓ | ↓ | ↓ | ↓ |
| Diarrhea | - | - | +++ | ++ | + | + |
“-“: none; “+, ++, +++“: mild, moderate and severe.
“N”: normal; “↓, ↓↓, ↓↓↓“: mild, moderate and severe decrease.
Figure 2.Effect of doxepin treatment on the histological structure of RILI rats. (A) HE staining in C group (B) HE staining in D group (C) HE staining in X group (D) HE staining in XMD group (E) HE staining pathological score in each group (F) Measurement of hydroxyproline content in each group. Scale bars =100 μm.
Hematoxylin and eosin staining pathological score.
| Pathological Score | Histopathological Features | |
|---|---|---|
| Inflammation and fibrosis score | Range of inflammatory cells and amorphous material in the alveolar space | 0–2 |
| (0–15) | Extent of inflammatory cells and amorphous material in the alveolar space | 0–2 |
| Interstitial fibrosis | 0–5 | |
| Range of bronchial wall fibrosis | 0–2 | |
| Extent of bronchial fibrosis | 0–2 | |
| Thickening of alveolar walls | 0–2 |
Figure 3.Effects of Doxepin on WBC and CRP Expression in RILI Rats. (A) CRP values in groups C, D, X, and XMD at 12 weeks. (B)WBC (count/ml of blood) time curve of group C, group D, group X, group XMD. (see Table 3 for details) (aP <.05 vs control group and bP <.05 vs X-ray group).
Levels of C-reactive protein and white blood cell in the rats in the C, X, and XMD groups.
| C group | D group | X group | XMD group | |
|---|---|---|---|---|
| WBC (count/ml) | 7450 ± 501 | 7300 ± 438 | 12 433 ± 463 | 8467 ± 739 |
| CRP (mg/L) | 2.275 ± .520 | 2.306 ± .551 | 11.376 ±1.249 | 4.925 ± .890 |
Figure 4.Effects of doxepin on the expression of NF-κβ and JNK in RILI rats. (A) The expression of NF-κβ and JNK protein in each group increased. (B) and (C) quantitative analysis of relative protein expression for NF-κβ and JNK detected by Western blot. (D) Quantitative analysis of relative mRNA expression for NF-κβ and JNK detected by quantitative real-time PCR(aP <.05 vs control group and bP <.05 vs X-ray group). Each value represents mean± SEM (n = 8).